Mandeg, Luisa D.

HRN: 14-85-62  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/01/2025
CEFUROXIME 500MG (TAB)
09/01/2025
09/09/2025
PO
500mg
BID
S/PEvacuation Curettage
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines